Esophageal Adenocarcinomas clinical trials at UC Cancer
1 research study open to eligible people
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
open to eligible people ages 18 years and up
A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumors